Clinical Trial Update: Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating trastuzumab or lapatinib ditosylate in women with early breast cancer; status and results not provided here.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib Ditosylate (lapatinib ditosylate)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN